𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

✍ Scribed by Mudaliar, Sunder; Henry, Robert R.; Sanyal, Arun J.; Morrow, Linda; Marschall, Hanns–Ulrich; Kipnes, Mark; Adorini, Luciano; Sciacca, Cathi I.; Clopton, Paul; Castelloe, Erin; Dillon, Paul; Pruzanski, Mark; Shapiro, David


Book ID
121308433
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
659 KB
Volume
145
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES